The store will not work correctly when cookies are disabled.
US8629135, SW-09
ID: ALA3693951
PubChem CID: 434800
Max Phase: Preclinical
Molecular Formula: C17H20N2
Molecular Weight: 252.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)CCNC1c2ccccc2-c2ccccc21
Standard InChI: InChI=1S/C17H20N2/c1-19(2)12-11-18-17-15-9-5-3-7-13(15)14-8-4-6-10-16(14)17/h3-10,17-18H,11-12H2,1-2H3
Standard InChI Key: GQNUPLZPYCRVRN-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
8.5280 -3.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3538 -3.3681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9812 -4.5088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3509 -2.2515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8823 -2.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8794 -1.4442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5701 -4.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0400 -5.5491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5318 -5.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4135 -4.4923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 7 1 0
19 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 252.36 | Molecular Weight (Monoisotopic): 252.1626 | AlogP: 2.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 15.27 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.76 | CX LogP: 3.01 | CX LogD: 1.64 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.90 | Np Likeness Score: -0.52 |
References
1. (2014) Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer, |